Latest filing published 22 Dec 2025 for ASP Isotopes Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Todd Wider (board member) discloses dealings in 2 companies, chiefly Abeona Therapeutics Inc. and ASP Isotopes Inc. In total, 34 filings cover trades dated from 11 May 2015 to 18 December 2025.
On the open market, the record shows 2 purchases worth €125k and 9 sales worth €1.8M. Netting one side against the other leaves €1.7M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 13 share grants and 9 option exercises. 2025 to date brings no purchases and 1 sale.
The record was last updated on 22 December 2025 with a share grant in ASP Isotopes Inc. The last purchase on record was published on 28 September 2016, which is 3,679 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations